Abstract

2022 Background: The standard treatment in children with average-risk medulloblastoma (MB) is chemotherapy after reduced-dose radiotherapy (23.4 Gy of craniospinal irradiation and a posterior fossa...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
E Franceschi ... A Paccapelo
Journal of Neuro-Oncology | VOL. 128
E Franceschi, et. al.E Franceschi ... A Paccapelo
03 Mar 2016
Concurrent Chemotherapy and Reduced-Dose Cranial Spinal Irradiation followed by Posterior Fossa Tumor Bed Boost for Average-Risk Medulloblastoma: Efficacy and Patterns of Failure
R.P Ermoian ... J.G Douglas
International Journal of Radiation Oncology, Biology, Physics | VOL. 78
R.P Ermoian, et. al.R.P Ermoian ... J.G Douglas
30 Sep 2010
A multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma
T.E Merchant ... A Gajjar
International Journal of Radiation Oncology, Biology, Physics | VOL. 57
T.E Merchant, et. al.T.E Merchant ... A Gajjar
03 Sep 2003
Role of amifostine as a cytoprotectant in children ≥ 3 years with average risk (AR) medulloblastoma (MB) treated with craniospinal irradiation (CSI) and 4 courses of cisplatin (CDDP)-based high dose chemotherapy
M Fouladi ... C Stewart
Journal of Clinical Oncology | VOL. 24
M Fouladi, et. al.M Fouladi ... C Stewart
20 Jun 2006
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.
Alexios Matikas ...
Journal of Clinical Oncology | VOL. -
Alexios Matikas, et. al.Alexios Matikas ...
17 Jul 2024
Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
Elias Campo ... Reiner Siebert
Journal of Clinical Oncology | VOL. -
Elias Campo, et. al.Elias Campo ... Reiner Siebert
17 Jul 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.
Brian C Shaffer ... Monzr M Al Malki
Journal of Clinical Oncology | VOL. -
Brian C Shaffer, et. al.Brian C Shaffer ... Monzr M Al Malki
17 Jul 2024
Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Steven J Katz ... Allison W Kurian
Journal of Clinical Oncology | VOL. -
Steven J Katz, et. al.Steven J Katz ... Allison W Kurian
15 Jul 2024
View more papers